Company intelligence / Profile preview

Hear Now

Gardena, California, United States

Ownership: Private
Development stage: Other

Overview

Hear Now is a private U.S. hearing care company focused on assessment and treatment of hearing loss and tinnitus, with particular emphasis on noise-induced hearing loss and industrial deafness. The company offers hearing evaluations, audiology services, and hearing-aid solutions through multiple clinic locations. Its website positions the business as a long-running provider that has operated since 1995 and serves patients through personalized hearing care and access to hearing devices. Hear Now appears to be a commercial healthcare services company rather than a drug-development biotech or pharma company, and there is no evidence of a therapeutic R&D pipeline.

Therapeutic areas: NeurologyOther
Modalities: DeviceNon-pharmacological therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Hear Now.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hear Now.

Explore the full profile